Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.

Stephane Heymans, Matthias Pauschinger (Co-author), Armando De Palma, Angela Kallwellis-Opara, Susanne Rutschow, Melissa Swinnen, Davy Vanhoutte, Fangye Gao, Raimund Torpai, Andrew H Baker, Elisabeth Padalko, Johan Neyts, Heinz-Peter Schultheiss, Frans Van de Werf, Peter Carmeliet, Yigal M Pinto

    Research output: Contribution to journalOriginal Articlepeer-review

    88 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)565-573
    JournalCIRCULATION
    Volume114
    Issue number6
    DOIs
    Publication statusPublished - 2006

    Keywords

    • HEART-DISEASE
    • MURINE MYOCARDITIS
    • TARGETED DELETION
    • IMMUNE-RESPONSE
    • TENASCIN-C
    • GROUP-B
    • MICE
    • CARDIOMYOPATHY
    • INFLAMMATION
    • ASSOCIATION

    Cite this